Eli Lilly (LLY) stock in focus as a federal appeals court upholds a lower court ruling which ordered the company to pay ...

Office cluster with Takeda HQ refinances for $1.3B Lilly’s latest $1B+ obesity deal is with Boston biotech Lilly’s latest ...

One government official said pharmaceutical companies around the world were changing their long-term business plans in response to pressure from Trump to invest more in the US. It was “spin” on the ...

Drug giant's "common-sense" price scheme ruled illegal by federal court, upholding over $183 million in damages. The United ...

A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a whistleblowing lawyer ...

Building in Houston expands Eli Lilly’s United States production at a time when its competitor, Novo Nordisk, maker of ...

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

The deal includes AI-powered software for detecting known side effects of recently launched Alzheimer’s drugs.

In recent years, Lilly's top line has been growing at a much faster pace thanks to its already approved GLP-1 injections, ...

A $193 million award against Eli Lilly and Co. in a False Claims Act suit alleging Medicaid fraud will stand, the Seventh Circuit ruled Thursday.

Baxdrostat, a selective aldosterone synthase inhibitor, lowered BP and albuminuria in patients with uncontrolled hypertension ...

Takeda names Rhonda Pacheco as U.S. Business Unit President, bringing expertise from Eli Lilly. Read more here.